薬理ゲノミクス（PGx）の世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9101994）

◆英語タイトル：Global Pharmacogenomics (PGx) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9101994
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年9月（※2024年版があります。お問い合わせください）
◆ページ数：136
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥515,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥772,560	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,030,080	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、薬理ゲノミクス（PGx）の世界市場について調べ、まとめました。種類別セグメントは、ポリメラーゼ連鎖反応（PCR）、マイクロアレイ、シーケンス、その他等、用途別セグメントは、心血管疾患（CVD）、中枢神経系（CNS）、がん/腫瘍学、感染症、その他等に区分しました。薬理ゲノミクス（PGx）の世界市場概観、企業動向、企業別薬理ゲノミクス（PGx）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・薬理ゲノミクス（PGx）の市場概観
・薬理ゲノミクス（PGx）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・薬理ゲノミクス（PGx）の企業別販売動向、市場シェア、市場集中度、競争動向
・薬理ゲノミクス（PGx）の世界市場規模
・薬理ゲノミクス（PGx）の北米市場分析（アメリカ、カナダ、メキシコ等）
・薬理ゲノミクス（PGx）のアメリカ市場規模推移
・薬理ゲノミクス（PGx）のカナダ市場規模推移
・薬理ゲノミクス（PGx）のメキシコ市場規模推移
・薬理ゲノミクス（PGx）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・薬理ゲノミクス（PGx）のドイツ市場規模推移
・薬理ゲノミクス（PGx）のイギリス市場規模推移
・薬理ゲノミクス（PGx）のロシア市場規模推移
・薬理ゲノミクス（PGx）のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・薬理ゲノミクス（PGx）の日本市場規模推移
・薬理ゲノミクス（PGx）の中国市場規模推移
・薬理ゲノミクス（PGx）の韓国市場規模推移
・薬理ゲノミクス（PGx）のインド市場規模推移
・薬理ゲノミクス（PGx）の東南アジア市場規模推移
・薬理ゲノミクス（PGx）の南米市場分析（ブラジル、アルゼンチン等）
・薬理ゲノミクス（PGx）の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・薬理ゲノミクス（PGx）の種類別分析/販売量、売上、市場シェア（ポリメラーゼ連鎖反応（PCR）、マイクロアレイ、シーケンス、その他）
・薬理ゲノミクス（PGx）の用途別分析/市場規模（心血管疾患（CVD）、中枢神経系（CNS）、がん/腫瘍学、感染症、その他）
・薬理ゲノミクス（PGx）の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・薬理ゲノミクス（PGx）の販売チャネル・代理店・貿易業者・ディーラー分析

【レポートの概要】

Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs.

Scope of the Report:
The global Pharmacogenomics (PGx) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pharmacogenomics (PGx).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Pharmacogenomics (PGx) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pharmacogenomics (PGx) market by product type and applications/end industries.

Market Segment by Companies, this report covers
Abbott Laboratories
Affymetrix, Inc.
Assurex Health, Inc
Astrazeneca
GeneDX
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
Pathway Genomics
Pfizer, Inc
Qiagen, Inc.
Rocheg
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
Transgenomic, Inc.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Polymerase Chain Reaction (PCR)
Microarray
Sequencing
Other

Market Segment by Applications, can be divided into
Cardiovascular Diseases (CVD)
Central Nervous System (CNS)
Cancer/Oncology
Infectious Diseases
Other

【レポートの目次】

Table of Contents

1 Pharmacogenomics (PGx) Market Overview
1.1 Product Overview and Scope of Pharmacogenomics (PGx)
1.2 Classification of Pharmacogenomics (PGx) by Types
1.2.1 Global Pharmacogenomics (PGx) Revenue Comparison by Types (2019-2024)
1.2.2 Global Pharmacogenomics (PGx) Revenue Market Share by Types in 2018
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Microarray
1.2.5 Sequencing
1.2.6 Other
1.3 Global Pharmacogenomics (PGx) Market by Application
1.3.1 Global Pharmacogenomics (PGx) Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cardiovascular Diseases (CVD)
1.3.3 Central Nervous System (CNS)
1.3.4 Cancer/Oncology
1.3.5 Infectious Diseases
1.3.6 Other
1.4 Global Pharmacogenomics (PGx) Market by Regions
1.4.1 Global Pharmacogenomics (PGx) Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Pharmacogenomics (PGx) Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Pharmacogenomics (PGx) Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pharmacogenomics (PGx) Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Pharmacogenomics (PGx) Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pharmacogenomics (PGx) Status and Prospect (2014-2024)
1.5 Global Market Size of Pharmacogenomics (PGx) (2014-2024)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Pharmacogenomics (PGx) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.2 Affymetrix, Inc.
2.2.1 Business Overview
2.2.2 Pharmacogenomics (PGx) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.3 Assurex Health, Inc
2.3.1 Business Overview
2.3.2 Pharmacogenomics (PGx) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.4 Astrazeneca
2.4.1 Business Overview
2.4.2 Pharmacogenomics (PGx) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Astrazeneca Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.5 GeneDX
2.5.1 Business Overview
2.5.2 Pharmacogenomics (PGx) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GeneDX Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.6 Illumina, Inc.
2.6.1 Business Overview
2.6.2 Pharmacogenomics (PGx) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Illumina, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.7 Laboratory Corporation of America Holdings
2.7.1 Business Overview
2.7.2 Pharmacogenomics (PGx) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.8 Myriad Genetics, Inc.
2.8.1 Business Overview
2.8.2 Pharmacogenomics (PGx) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.9 Pathway Genomics
2.9.1 Business Overview
2.9.2 Pharmacogenomics (PGx) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pathway Genomics Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.10 Pfizer, Inc
2.10.1 Business Overview
2.10.2 Pharmacogenomics (PGx) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.11 Qiagen, Inc.
2.11.1 Business Overview
2.11.2 Pharmacogenomics (PGx) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.12 Rocheg
2.12.1 Business Overview
2.12.2 Pharmacogenomics (PGx) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Rocheg Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.13 Teva Pharmaceutical Industries Ltd.
2.13.1 Business Overview
2.13.2 Pharmacogenomics (PGx) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.14 Thermo Fisher Scientific
2.14.1 Business Overview
2.14.2 Pharmacogenomics (PGx) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
2.15 Transgenomic, Inc.
2.15.1 Business Overview
2.15.2 Pharmacogenomics (PGx) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pharmacogenomics (PGx) Market Competition, by Players
3.1 Global Pharmacogenomics (PGx) Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Pharmacogenomics (PGx) Players Market Share
3.2.2 Top 10 Pharmacogenomics (PGx) Players Market Share
3.3 Market Competition Trend
4 Global Pharmacogenomics (PGx) Market Size by Regions
4.1 Global Pharmacogenomics (PGx) Revenue and Market Share by Regions
4.2 North America Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
4.3 Europe Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
4.5 South America Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
5 North America Pharmacogenomics (PGx) Revenue by Countries
5.1 North America Pharmacogenomics (PGx) Revenue by Countries (2014-2019)
5.2 USA Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
5.3 Canada Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
5.4 Mexico Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
6 Europe Pharmacogenomics (PGx) Revenue by Countries
6.1 Europe Pharmacogenomics (PGx) Revenue by Countries (2014-2019)
6.2 Germany Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
6.3 UK Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
6.4 France Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
6.5 Russia Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
6.6 Italy Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Pharmacogenomics (PGx) Revenue by Countries
7.1 Asia-Pacific Pharmacogenomics (PGx) Revenue by Countries (2014-2019)
7.2 China Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
7.3 Japan Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
7.4 Korea Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
7.5 India Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
8 South America Pharmacogenomics (PGx) Revenue by Countries
8.1 South America Pharmacogenomics (PGx) Revenue by Countries (2014-2019)
8.2 Brazil Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
8.3 Argentina Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
8.4 Colombia Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Pharmacogenomics (PGx) by Countries
9.1 Middle East and Africa Pharmacogenomics (PGx) Revenue by Countries (2014-2019)
9.2 Saudi Arabia Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
9.3 UAE Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
9.4 Egypt Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
9.5 Nigeria Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
9.6 South Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
10 Global Pharmacogenomics (PGx) Market Segment by Type
10.1 Global Pharmacogenomics (PGx) Revenue and Market Share by Type (2014-2019)
10.2 Global Pharmacogenomics (PGx) Market Forecast by Type (2019-2024)
10.3 Polymerase Chain Reaction (PCR) Revenue Growth Rate (2014-2024)
10.4 Microarray Revenue Growth Rate (2014-2024)
10.5 Sequencing Revenue Growth Rate (2014-2024)
10.6 Other Revenue Growth Rate (2014-2024)
11 Global Pharmacogenomics (PGx) Market Segment by Application
11.1 Global Pharmacogenomics (PGx) Revenue Market Share by Application (2014-2019)
11.2 Pharmacogenomics (PGx) Market Forecast by Application (2019-2024)
11.3 Cardiovascular Diseases (CVD) Revenue Growth (2014-2019)
11.4 Central Nervous System (CNS) Revenue Growth (2014-2019)
11.5 Cancer/Oncology Revenue Growth (2014-2019)
11.6 Infectious Diseases Revenue Growth (2014-2019)
11.7 Other Revenue Growth (2014-2019)
12 Global Pharmacogenomics (PGx) Market Size Forecast (2019-2024)
12.1 Global Pharmacogenomics (PGx) Market Size Forecast (2019-2024)
12.2 Global Pharmacogenomics (PGx) Market Forecast by Regions (2019-2024)
12.3 North America Pharmacogenomics (PGx) Revenue Market Forecast (2019-2024)
12.4 Europe Pharmacogenomics (PGx) Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Pharmacogenomics (PGx) Revenue Market Forecast (2019-2024)
12.6 South America Pharmacogenomics (PGx) Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Pharmacogenomics (PGx) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Pharmacogenomics (PGx) Picture
Table Product Specifications of Pharmacogenomics (PGx)
Table Global Pharmacogenomics (PGx) and Revenue (Million USD) Market Split by Product Type
Figure Global Pharmacogenomics (PGx) Revenue Market Share by Types in 2018
Figure Polymerase Chain Reaction (PCR) Picture
Figure Microarray Picture
Figure Sequencing Picture
Figure Other Picture
Table Global Pharmacogenomics (PGx) Revenue (Million USD) by Application (2014-2024)
Figure Pharmacogenomics (PGx) Revenue Market Share by Applications in 2018
Figure Cardiovascular Diseases (CVD) Picture
Figure Central Nervous System (CNS) Picture
Figure Cancer/Oncology Picture
Figure Infectious Diseases Picture
Figure Other Picture
Table Global Market Pharmacogenomics (PGx) Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (2014-2024)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Pharmacogenomics (PGx) Type and Applications
Table Abbott Laboratories Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Affymetrix, Inc. Basic Information, Manufacturing Base and Competitors
Table Affymetrix, Inc. Pharmacogenomics (PGx) Type and Applications
Table Affymetrix, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Assurex Health, Inc Basic Information, Manufacturing Base and Competitors
Table Assurex Health, Inc Pharmacogenomics (PGx) Type and Applications
Table Assurex Health, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Astrazeneca Basic Information, Manufacturing Base and Competitors
Table Astrazeneca Pharmacogenomics (PGx) Type and Applications
Table Astrazeneca Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table GeneDX Basic Information, Manufacturing Base and Competitors
Table GeneDX Pharmacogenomics (PGx) Type and Applications
Table GeneDX Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Illumina, Inc. Basic Information, Manufacturing Base and Competitors
Table Illumina, Inc. Pharmacogenomics (PGx) Type and Applications
Table Illumina, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Laboratory Corporation of America Holdings Basic Information, Manufacturing Base and Competitors
Table Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Type and Applications
Table Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Myriad Genetics, Inc. Basic Information, Manufacturing Base and Competitors
Table Myriad Genetics, Inc. Pharmacogenomics (PGx) Type and Applications
Table Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Pathway Genomics Basic Information, Manufacturing Base and Competitors
Table Pathway Genomics Pharmacogenomics (PGx) Type and Applications
Table Pathway Genomics Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table Pfizer, Inc Pharmacogenomics (PGx) Type and Applications
Table Pfizer, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Qiagen, Inc. Basic Information, Manufacturing Base and Competitors
Table Qiagen, Inc. Pharmacogenomics (PGx) Type and Applications
Table Qiagen, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Rocheg Basic Information, Manufacturing Base and Competitors
Table Rocheg Pharmacogenomics (PGx) Type and Applications
Table Rocheg Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Type and Applications
Table Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific Pharmacogenomics (PGx) Type and Applications
Table Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Transgenomic, Inc. Basic Information, Manufacturing Base and Competitors
Table Transgenomic, Inc. Pharmacogenomics (PGx) Type and Applications
Table Transgenomic, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2018)
Table Global Pharmacogenomics (PGx) Revenue (Million USD) by Players (2014-2019)
Table Global Pharmacogenomics (PGx) Revenue Share by Players (2014-2019)
Figure Global Pharmacogenomics (PGx) Revenue Share by Players in 2017
Figure Global Pharmacogenomics (PGx) Revenue Share by Players in 2018
Figure Global Top 5 Players Pharmacogenomics (PGx) Revenue Market Share in 2018
Figure Global Top 10 Players Pharmacogenomics (PGx) Revenue Market Share in 2018
Figure Global Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Pharmacogenomics (PGx) Revenue (Million USD) by Regions (2014-2019)
Table Global Pharmacogenomics (PGx) Revenue Market Share by Regions (2014-2019)
Figure Global Pharmacogenomics (PGx) Revenue Market Share by Regions (2014-2019)
Figure Global Pharmacogenomics (PGx) Revenue Market Share by Regions in 2018
Figure North America Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Europe Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure South America Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Table North America Pharmacogenomics (PGx) Revenue by Countries (2014-2019)
Table North America Pharmacogenomics (PGx) Revenue Market Share by Countries (2014-2019)
Figure North America Pharmacogenomics (PGx) Revenue Market Share by Countries (2014-2019)
Figure North America Pharmacogenomics (PGx) Revenue Market Share by Countries in 2018
Figure USA Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Canada Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Mexico Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Table Europe Pharmacogenomics (PGx) Revenue (Million USD) by Countries (2014-2019)
Figure Europe Pharmacogenomics (PGx) Revenue Market Share by Countries (2014-2019)
Figure Europe Pharmacogenomics (PGx) Revenue Market Share by Countries in 2018
Figure Germany Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure UK Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure France Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Russia Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Italy Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Pharmacogenomics (PGx) Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Pharmacogenomics (PGx) Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Pharmacogenomics (PGx) Revenue Market Share by Countries in 2018
Figure China Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Japan Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Korea Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure India Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Table South America Pharmacogenomics (PGx) Revenue by Countries (2014-2019)
Table South America Pharmacogenomics (PGx) Revenue Market Share by Countries (2014-2019)
Figure South America Pharmacogenomics (PGx) Revenue Market Share by Countries (2014-2019)
Figure South America Pharmacogenomics (PGx) Revenue Market Share by Countries in 2018
Figure Brazil Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Argentina Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Colombia Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Pharmacogenomics (PGx) Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Pharmacogenomics (PGx) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pharmacogenomics (PGx) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pharmacogenomics (PGx) Revenue Market Share by Countries in 2018
Figure Saudi Arabia Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure UAE Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Egypt Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure Nigeria Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Figure South Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2014-2019)
Table Global Pharmacogenomics (PGx) Revenue (Million USD) by Type (2014-2019)
Table Global Pharmacogenomics (PGx) Revenue Share by Type (2014-2019)
Figure Global Pharmacogenomics (PGx) Revenue Share by Type (2014-2019)
Figure Global Pharmacogenomics (PGx) Revenue Share by Type in 2019
Table Global Pharmacogenomics (PGx) Revenue Forecast by Type (2019-2024)
Figure Global Pharmacogenomics (PGx) Market Share Forecast by Type (2019-2024)
Figure Global Polymerase Chain Reaction (PCR) Revenue Growth Rate (2014-2019)
Figure Global Microarray Revenue Growth Rate (2014-2019)
Figure Global Sequencing Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Pharmacogenomics (PGx) Revenue by Application (2014-2019)
Table Global Pharmacogenomics (PGx) Revenue Share by Application (2014-2019)
Figure Global Pharmacogenomics (PGx) Revenue Share by Application (2014-2019)
Figure Global Pharmacogenomics (PGx) Revenue Share by Application in 2019
Table Global Pharmacogenomics (PGx) Revenue Forecast by Application (2019-2024)
Figure Global Pharmacogenomics (PGx) Market Share Forecast by Application (2019-2024)
Figure Global Cardiovascular Diseases (CVD) Revenue Growth Rate (2014-2019)
Figure Global Central Nervous System (CNS) Revenue Growth Rate (2014-2019)
Figure Global Cancer/Oncology Revenue Growth Rate (2014-2019)
Figure Global Infectious Diseases Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Pharmacogenomics (PGx) Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Pharmacogenomics (PGx) Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Pharmacogenomics (PGx) Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Pharmacogenomics (PGx) Revenue Market Forecast (2019-2024)
Figure Europe Pharmacogenomics (PGx) Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Pharmacogenomics (PGx) Revenue Market Forecast (2019-2024)
Figure South America Pharmacogenomics (PGx) Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Pharmacogenomics (PGx) Revenue Market Forecast (2019-2024)

【掲載企業】

Abbott Laboratories、Affymetrix, Inc.、Assurex Health, Inc、Astrazeneca、GeneDX、Illumina, Inc.、Laboratory Corporation of America Holdings、Myriad Genetics, Inc.、Pathway Genomics、Pfizer, Inc、Qiagen, Inc.、Rocheg、Teva Pharmaceutical Industries Ltd.、Thermo Fisher Scientific、Transgenomic, Inc.、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 薬理ゲノミクス（PGx）の世界市場2019(Global Pharmacogenomics (PGx) Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp